Statin-Induced Geranylgeranyl Pyrophosphate Depletion Promotes PCSK9–Dependent Adipose Insulin Resistance
出版年份 2022 全文链接
标题
Statin-Induced Geranylgeranyl Pyrophosphate Depletion Promotes PCSK9–Dependent Adipose Insulin Resistance
作者
关键词
-
出版物
Nutrients
Volume 14, Issue 24, Pages 5314
出版商
MDPI AG
发表日期
2022-12-15
DOI
10.3390/nu14245314
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Statin-Induced Geranylgeranyl Pyrophosphate Depletion Promotes Ferroptosis-Related Senescence in Adipose Tissue
- (2022) Xin Shu et al. Nutrients
- Association of Statin Therapy Initiation With Diabetes Progression
- (2021) Ishak A. Mansi et al. JAMA Internal Medicine
- Liver governs adipose remodelling via extracellular vesicles in response to lipid overload
- (2020) Yue Zhao et al. Nature Communications
- PCSK9 Expression in Epicardial Adipose Tissue: Molecular Association with Local Tissue Inflammation
- (2020) Elena Dozio et al. MEDIATORS OF INFLAMMATION
- PCSK9 is Expressed in Human Visceral Adipose Tissue and Regulated by Insulin and Cardiac Natriuretic Peptides
- (2019) Marica Bordicchia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents
- (2019) C Macchi et al. European Journal of Preventive Cardiology
- Statins Promote IL-1β-Dependent Adipocyte Insulin Resistance via Lower Prenylation not Cholesterol
- (2019) Brandyn D. Henriksbo et al. DIABETES
- Statins Reduce Epicardial Adipose Tissue Attenuation Independent of Lipid Lowering: A Potential Pleiotropic Effect
- (2019) Paolo Raggi et al. Journal of the American Heart Association
- PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor
- (2018) Lorenzo Da Dalt et al. EUROPEAN HEART JOURNAL
- Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue
- (2018) Valentina Parisi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
- (2017) Amand F Schmidt et al. Lancet Diabetes & Endocrinology
- Geranylgeranyl pyrophosphate performs as an endogenous regulator of adipocyte function via suppressing the LXR pathway
- (2016) Yu-Sheng Yeh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk FactorsCLINICAL PERSPECTIVE
- (2016) Karin Leander et al. CIRCULATION
- A review of PCSK9 inhibition and its effects beyond LDL receptors
- (2016) Dave L. Dixon et al. Journal of Clinical Lipidology
- Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta-analysis of clinical trials
- (2015) A. Sahebkar et al. DIABETES OBESITY & METABOLISM
- HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
- (2015) Daniel I Swerdlow et al. LANCET
- Fluvastatin Causes NLRP3 Inflammasome-Mediated Adipose Insulin Resistance
- (2014) Brandyn D. Henriksbo et al. DIABETES
- Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
- (2013) Eliano Pio Navarese et al. AMERICAN JOURNAL OF CARDIOLOGY
- Circulating Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Regulates VLDLR Protein and Triglyceride Accumulation in Visceral Adipose Tissue
- (2011) Anna Roubtsova et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study
- (2011) M.C.G.J. Brouwers et al. ATHEROSCLEROSIS
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
- (2011) David Preiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters
- (2010) Bin Dong et al. JOURNAL OF LIPID RESEARCH
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Genetic and Metabolic Determinants of Plasma PCSK9 Levels
- (2009) Susan G. Lakoski et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of High-Dose Simvastatin Therapy on Glucose Metabolism and Ectopic Lipid Deposition in Nonobese Type 2 Diabetic Patients
- (2008) J. Szendroedi et al. DIABETES CARE
- Statin modulates insulin signaling and insulin resistance in liver and muscle of rats fed a high-fat diet
- (2007) Cristina Alba Lalli et al. METABOLISM-CLINICAL AND EXPERIMENTAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation